RMD (ResMed Inc.)
All Pro Portfolios with RMD
All Do-It-Yourself Portfolios with RMD
- Total Do-It-Yourself Portfolios with RMD:
- SeaDog
- chris booker Portfolio 1
- Cha Ching
- JustinT294 Portfolio 1
- G1NA
- Stars of Yesterday
- aszliter Portfolio 1
- SUPRATRADE THURSDAY PICK IV
- snoglp 1
- gone fishing
- brutusd9
- 07a
- choanser Portfolio 1
- ourretirement
- Cramer's Medicare Stock Plays
- ThomasBoomer1
- Green Equity
- show more
- 34
- SmallCap_POS_MA
- Jeff Philip Portfolio 1
- brick,stick&wire
- LTG1
- mendod Portfolio 1
- holmgn Portfolio 1
- ShooterMcGavin Portfolio 1
- Bugts
- JOHNABBRUZZESI PORTFOLIO 3
- gbw
- fed9 earnings growth >10%, peg<2,
- nazdagg Portfolio 1
- Possible Stocks to Watch2
- PART 2 JPMorgan 26th Annual Healthcare Conf 1/7/08..1st Day Reporting Companies..Nymph Take
- OLIVER JAMES
- RAPTOR SPRTD-2811081414
- PART 2 JPMorgan 27th Annual Healthcare Conf 1/12/09..1st Day Reporting Companies..Nymph Take
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:12 30 08 |
|
3:30 |
|
Not yet rated
Rate now:
|
|
By:RAPTOR I |
Date:11 28 08 |
* Agressive Growth - ResMed (RMD) announced record quarterly |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:07 02 08 |
New Medicare rules will also provide reimbursements for in-home testing of sleep apnea. ResMed makes in-home testing and treatment equipment, so the company is in a great position to benefit as more people will be tested and need its products. Cramer said the stock could soar to $50 to $53 a share, but he cautioned investors to wait for a pullback after the shares ran up 7% today on takeover rumors. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Altucher's 10-Bagger of the Week: Obesity |
|
Not yet rated
Rate now:
|
|
Date:11 07 07 |
|
Sleep disordered breathing is under-diagnosed and a serious issue. Sleep center beds are expected to grow at a a rate of about 15%-18%, which means more demand for ResMed's products. Part of a duopoly market alongside Respironics (RESP). ResMed has an industry reputation for better products at a slightly higher price. |
|
Not yet rated
Rate now:
|
|
By:tilak |
Date:10 10 07 |
ResMed, Inc. |
|
Not yet rated
Rate now:
|
|
By:rick1533 |
Date:07 11 07 |
cpap user |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Upgraded by BMO Capital Markets from Mkt Perform to Outperform |
|
Not yet rated
Rate now:
|
|
By:dgbon |
Date:04 06 07 |
Solid growth - interesting product |
|
Not yet rated
Rate now:
|
|
By:supratrade |
Date:04 05 07 |
Ratings change: buy, Price target: USD 59 |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |